omeprazole has been researched along with Infections, Yersinia in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Septicemia occurred in a long-term hemodialysis patient on oral iron supplementation who had been treated for esophageal ulcer by omeprazole, an ulcer-healing drug." | 3.68 | Septicemia due to Yersinia enterocolitica in a hemodialyzed, iron-depleted patient receiving omeprazole and oral iron supplementation. ( Fakir, M; Hardin, JM; Matta, B; Saison, C; Wong, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handley, SA | 1 |
| Dube, PH | 1 |
| Miller, VL | 1 |
| Fakir, M | 1 |
| Saison, C | 1 |
| Wong, T | 1 |
| Matta, B | 1 |
| Hardin, JM | 1 |
2 other studies available for omeprazole and Infections, Yersinia
| Article | Year |
|---|---|
Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection.
Topics: Animals; Anti-Allergic Agents; Anti-Ulcer Agents; Cimetidine; Dimaprit; Female; Gene Expression Prof | 2006 |
Septicemia due to Yersinia enterocolitica in a hemodialyzed, iron-depleted patient receiving omeprazole and oral iron supplementation.
Topics: Aged; Anemia, Hypochromic; Bacteremia; Esophageal Diseases; Female; Ferrous Compounds; Humans; Omepr | 1992 |